These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 9753519)

  • 1. Asthma treatment: inhaled beta-agonists.
    Sears MR
    Can Respir J; 1998; 5 Suppl A():54A-9A. PubMed ID: 9753519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of inhaled formoterol in the treatment of asthma.
    Berger WE
    Ann Allergy Asthma Immunol; 2006 Jul; 97(1):24-33. PubMed ID: 16892777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Budesonide/formoterol for maintenance and relief in uncontrolled asthma vs. high-dose salmeterol/fluticasone.
    Bousquet J; Boulet LP; Peters MJ; Magnussen H; Quiralte J; Martinez-Aguilar NE; Carlsheimer A
    Respir Med; 2007 Dec; 101(12):2437-46. PubMed ID: 17905575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A benefit-risk assessment of inhaled long-acting beta2-agonists in the management of obstructive pulmonary disease.
    Sovani MP; Whale CI; Tattersfield AE
    Drug Saf; 2004; 27(10):689-715. PubMed ID: 15350154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of budesonide/formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma.
    Scicchitano R; Aalbers R; Ukena D; Manjra A; Fouquert L; Centanni S; Boulet LP; Naya IP; Hultquist C
    Curr Med Res Opin; 2004 Sep; 20(9):1403-18. PubMed ID: 15383189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formoterol. An update of its pharmacological properties and therapeutic efficacy in the management of asthma.
    Bartow RA; Brogden RN
    Drugs; 1998 Feb; 55(2):303-22. PubMed ID: 9506248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rescue treatment in asthma. More than as-needed bronchodilation.
    Papi A; Caramori G; Adcock IM; Barnes PJ
    Chest; 2009 Jun; 135(6):1628-1633. PubMed ID: 19497897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Budesonide/formoterol maintenance and reliever therapy: a new treatment approach for adult patients with asthma.
    Buhl R; Vogelmeier C
    Curr Med Res Opin; 2007 Aug; 23(8):1867-78. PubMed ID: 17605896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The long and short of beta2-agonists.
    Lötvall J
    Pulm Pharmacol Ther; 2002; 15(6):497-501. PubMed ID: 12493336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of persistent asthma with Symbicort (budesonide/formoterol inhalation aerosol): an inhaled corticosteroid and long-acting beta2-adrenergic agonist in one pressurized metered-dose inhaler.
    Berger WE; Noonan MJ
    J Asthma; 2010 May; 47(4):447-59. PubMed ID: 20528601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A retrospective database study comparing treatment outcomes and cost associated with choice of fixed-dose inhaled corticosteroid/long-acting beta-agonists for asthma maintenance treatment in Germany.
    Aballéa S; Cure S; Vogelmeier C; Wirén A
    Int J Clin Pract; 2008 Dec; 62(12):1870-9. PubMed ID: 18803555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-acting beta-agonist treatment in patients with persistent asthma already receiving inhaled corticosteroids.
    Hancox RJ; Taylor DR
    BioDrugs; 2001; 15(1):11-24. PubMed ID: 11437672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group.
    Pauwels RA; Löfdahl CG; Postma DS; Tattersfield AE; O'Byrne P; Barnes PJ; Ullman A
    N Engl J Med; 1997 Nov; 337(20):1405-11. PubMed ID: 9358137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Budesonide/formoterol maintenance plus reliever therapy: a new strategy in pediatric asthma.
    Bisgaard H; Le Roux P; Bjåmer D; Dymek A; Vermeulen JH; Hultquist C
    Chest; 2006 Dec; 130(6):1733-43. PubMed ID: 17166990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination corticosteroid/β-agonist inhaler as reliever therapy: a solution for intermittent and mild asthma?
    Beasley R; Weatherall M; Shirtcliffe P; Hancox R; Reddel HK
    J Allergy Clin Immunol; 2014 Jan; 133(1):39-41. PubMed ID: 24369798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Budesonide/formoterol maintenance and reliever therapy. A new treatment approach for adult patients with asthma].
    Korn S; Vogelmeier C; Buhl R
    Med Klin (Munich); 2008 May; 103(5):299-310. PubMed ID: 18484216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double trouble: impact of inappropriate use of asthma medication on the use of health care resources.
    Anis AH; Lynd LD; Wang XH; King G; Spinelli JJ; Fitzgerald M; Bai T; Paré P
    CMAJ; 2001 Mar; 164(5):625-31. PubMed ID: 11258208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse effects of beta-agonists: are they clinically relevant?
    Abramson MJ; Walters J; Walters EH
    Am J Respir Med; 2003; 2(4):287-97. PubMed ID: 14719995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current trends in asthma therapy.
    Sztanke K; Pasternak K
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(2):290-3. PubMed ID: 15323207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Managing symptoms and exacerbations in pediatric asthma.
    Verberne AA
    Pediatr Pulmonol Suppl; 1997 Sep; 15():46-50. PubMed ID: 9316102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.